![]() BellBrook Labs BellBrook Labs is a company providing discovery and optimization tools for researchers. | ![]() RS Research RS Research is a pharmaceutical company developing nanomedicines based on innovative drug delivery platforms for targeted cancer therapy. | ||||
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date 2002 | Founding Date 1978 | Founding Date 2015 |
Type | Type Public | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ Toronto, CA New York, US Stony Brook, US | Locations Woburn, US HQ Milton, GB Woburn, US | Locations Fitchburg, US HQ | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations Epalinges, CH HQ |
Employees | Employees 2456% decrease | Employees 10422% increase | Employees 176% decrease | Employees 16,5612% increase | Employees 254% decrease |
Valuation ($) | Valuation ($) 165 m | Valuation ($) 823.3 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $70m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) N/A |
Net income | Net income $22.4m (FY, 2025) | Net income ($247.3m) (FY, 2025) | Net income N/A | Net income ₹3.7b (FY, 2026) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 202.1m | Total funding raised $ 30m | Total funding raised $ 187.3k | Total funding raised N/A | Total funding raised N/A |

Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.
View company
BellBrook Labs is a company providing discovery and optimization tools for researchers.
View company
Biocon is a company that develops and manufactures biopharmaceutical products.
View company
RS Research is a pharmaceutical company developing nanomedicines based on innovative drug delivery platforms for targeted cancer therapy.
View company